Krass I; Bajorek Beata; Bagia M; Fragoudakis I; Ozgur B; Chin Sy Li
(Sage Publications Ltd, 1997)
Background. Bone marrow transplant (BMT) recipi ents, who receive high-dose cyclophosphamide as part of conditioning therapy, are at considerable risk of developing haemorrhagic cystitis (HC). The role of prophylaxis of ...